These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 28074905)
21. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9. Rao C; Miao X; Zhao G; Zhang C; Shen H; Dong C; Yang M Biomed Pharmacother; 2019 Jun; 114():108662. PubMed ID: 30999114 [TBL] [Abstract][Full Text] [Related]
22. TNFAIP2 Promotes Non-Small Cell Lung Cancer Cells and Targeted by miR-145-5p. Li J; Song Y; Yu B; Yu Y DNA Cell Biol; 2020 Jul; 39(7):1256-1263. PubMed ID: 32456459 [TBL] [Abstract][Full Text] [Related]
23. CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging. Zhang T; Zhang P; Li HX Int J Nanomedicine; 2021; 16():561-577. PubMed ID: 33542625 [TBL] [Abstract][Full Text] [Related]
24. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway. Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099 [TBL] [Abstract][Full Text] [Related]
25. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523 [TBL] [Abstract][Full Text] [Related]
26. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis. Huang Q; Xing S; Peng A; Yu Z Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894841 [TBL] [Abstract][Full Text] [Related]
27. MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray data. Lu M; Hu C; Wu F; Shu L; Pan Y; Liu X; Liu P; Ma F; Deng C; Huang M Lung Cancer; 2020 Sep; 147():193-197. PubMed ID: 32731058 [TBL] [Abstract][Full Text] [Related]
28. GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis. Cao L; Chen J; Ou B; Liu C; Zou Y; Chen Q Biomed Pharmacother; 2017 Sep; 93():570-579. PubMed ID: 28686971 [TBL] [Abstract][Full Text] [Related]
29. Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair. Yin JY; Shen J; Dong ZZ; Huang Q; Zhong MZ; Feng DY; Zhou HH; Zhang JT; Liu ZQ Clin Cancer Res; 2011 Jul; 17(13):4600-9. PubMed ID: 21610145 [TBL] [Abstract][Full Text] [Related]
30. The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells. Chen P; Li J; Chen YC; Qian H; Chen YJ; Su JY; Wu M; Lan T Cell Oncol (Dordr); 2016 Dec; 39(6):511-522. PubMed ID: 27473273 [TBL] [Abstract][Full Text] [Related]
31. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling. Huang RS; Zheng YL; Zhao J; Chun X Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202 [TBL] [Abstract][Full Text] [Related]
32. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells. Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026 [TBL] [Abstract][Full Text] [Related]
33. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis. Shao N; Song L; Sun X Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734 [TBL] [Abstract][Full Text] [Related]
34. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR. Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA‑875‑5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a. Chen T; Sun L; Yao B; Wang L; Wang Y; Niu Y; Liu R; Mo H; Liu Z; Tu K; Liu Q Oncol Rep; 2020 Nov; 44(5):2067-2079. PubMed ID: 33000235 [TBL] [Abstract][Full Text] [Related]
36. Garcinol Sensitizes NSCLC Cells to Standard Therapies by Regulating EMT-Modulating miRNAs. Farhan M; Malik A; Ullah MF; Afaq S; Faisal M; Farooqi AA; Biersack B; Schobert R; Ahmad A Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781783 [TBL] [Abstract][Full Text] [Related]
37. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET. Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910 [TBL] [Abstract][Full Text] [Related]
38. Targeting the miR-6734-3p/ZEB2 axis hampers development of non-small cell lung cancer (NSCLC) and increases susceptibility of cancer cells to cisplatin treatment. Wei L; Jiang J Bioengineered; 2021 Dec; 12(1):2499-2510. PubMed ID: 34107856 [TBL] [Abstract][Full Text] [Related]
39. CSB affected on the sensitivity of lung cancer cells to platinum-based drugs through the global decrease of let-7 and miR-29. Yang Z; Liu C; Wu H; Xie Y; Gao H; Zhang X BMC Cancer; 2019 Oct; 19(1):948. PubMed ID: 31615563 [TBL] [Abstract][Full Text] [Related]
40. Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis. Fu J; Cai H; Wu Y; Fang S; Wang D Gene; 2020 Sep; 755():144886. PubMed ID: 32534055 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]